• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

阿尔茨海默病中的能量消耗。

Energy expenditure in Alzheimer's disease.

作者信息

Poehlman E T, Dvorak R V

机构信息

Department of Medicine, University of Vermont, Burlington 05405, USA.

出版信息

J Nutr Health Aging. 1998;2(2):115-8.

PMID:10993580
Abstract

Alzheimer's disease type dementia is a growing health problem and is one of the leading causes of death among elderly people. Unexplained weight loss and cachexia is a frequent clinical finding in patients with Alzheimer's disease. It has been postulated that Alzheimer's disease may by characterized by dysfunction in body weight regulation. This brief review examines energy intake, energy expenditure and body composition in Alzheimer's disease. We consider whether inappropriately high levels of energy expenditure may contribute to unexplained weight loss and decline in nutritional status. Specifically, we will consider studies that have examined body composition, daily energy expenditure and its components. The application of doubly labeled water and indirect calorimetry to problems of "wasting" has increased our knowledge regarding energy expenditure and physical activity levels in Alzheimer's patients. Although the number of studies are limited, results do not support the notion that a "hypermetabolic" state contributes to unexplained weight loss in Alzheimer's disease, even in cachectic patients. Clinical strategies aimed at developing feeding strategies to maintain adequate caloric intake and the restoration of energy balance should be a future area of investigation in Alzheimer's research.

摘要

阿尔茨海默病型痴呆是一个日益严重的健康问题,也是老年人主要死因之一。不明原因的体重减轻和恶病质是阿尔茨海默病患者常见的临床症状。据推测,阿尔茨海默病可能以体重调节功能障碍为特征。本简要综述探讨了阿尔茨海默病患者的能量摄入、能量消耗和身体组成。我们考虑过高的能量消耗水平是否可能导致不明原因的体重减轻和营养状况下降。具体而言,我们将考虑那些研究身体组成、每日能量消耗及其组成部分的研究。双标记水法和间接测热法在“消瘦”问题上的应用增加了我们对阿尔茨海默病患者能量消耗和身体活动水平的了解。尽管研究数量有限,但结果并不支持“高代谢”状态导致阿尔茨海默病患者不明原因体重减轻这一观点,即使是恶病质患者也是如此。旨在制定喂养策略以维持足够热量摄入和恢复能量平衡的临床策略应成为阿尔茨海默病研究未来的一个调查领域。

相似文献

1
Energy expenditure in Alzheimer's disease.阿尔茨海默病中的能量消耗。
J Nutr Health Aging. 1998;2(2):115-8.
2
Energy balance in Alzheimer's disease.阿尔茨海默病中的能量平衡
J Nutr Health Aging. 2002;6(4):247-53.
3
Energy expenditure, energy intake, and weight loss in Alzheimer disease.阿尔茨海默病中的能量消耗、能量摄入与体重减轻
Am J Clin Nutr. 2000 Feb;71(2):650S-655S. doi: 10.1093/ajcn/71.2.650s.
4
Nutritional status of patients with Alzheimer's disease: a 1-year study.阿尔茨海默病患者的营养状况:一项为期1年的研究。
J Am Diet Assoc. 1996 Oct;96(10):1013-8. doi: 10.1016/S0002-8223(96)00270-2.
5
Energy requirements in Alzheimer's disease patients.阿尔茨海默病患者的能量需求。
Nutrition. 1995 May-Jun;11(3):264-8.
6
The energetics of wasting diseases.消耗性疾病的能量学
Curr Opin Clin Nutr Metab Care. 2007 Jul;10(4):488-93. doi: 10.1097/MCO.0b013e3281e38942.
7
Energy expenditure and wasting in human immunodeficiency virus infection.人类免疫缺陷病毒感染中的能量消耗与消瘦
N Engl J Med. 1995 Jul 13;333(2):83-8. doi: 10.1056/NEJM199507133330202.
8
[Alzheimer's disease and nutrition].[阿尔茨海默病与营养]
Rev Neurol (Paris). 1999 May;155(5):343-9.
9
A 6-month follow-up of nutritional status in institutionalized patients with Alzheimer's disease.对机构收容的阿尔茨海默病患者营养状况的6个月随访。
J Nutr Health Aging. 2004;8(6):505-8.
10
Nutritional modulation as part of the integrated management of chronic obstructive pulmonary disease.营养调节作为慢性阻塞性肺疾病综合管理的一部分。
Proc Nutr Soc. 2003 Nov;62(4):783-91. doi: 10.1079/PNS2003303.

引用本文的文献

1
Targeting whole body metabolism and mitochondrial bioenergetics in the drug development for Alzheimer's disease.在阿尔茨海默病药物研发中针对全身代谢和线粒体生物能量学
Acta Pharm Sin B. 2022 Feb;12(2):511-531. doi: 10.1016/j.apsb.2021.06.014. Epub 2021 Jun 30.
2
Targeted Metabolomic Analysis in Alzheimer's Disease Plasma and Brain Tissue in Non-Hispanic Whites.阿尔茨海默病患者血浆和脑组织中靶向代谢组学分析。
J Alzheimers Dis. 2022;86(4):1875-1895. doi: 10.3233/JAD-215448.
3
Serum Adiponectin Levels, Neuroimaging, and Cognition in the Mayo Clinic Study of Aging.
《梅奥诊所老龄化研究中的血清脂联素水平、神经影像学和认知》
J Alzheimers Dis. 2016 May 4;53(2):573-81. doi: 10.3233/JAD-151201.
4
Specific suppression of insulin sensitivity in growth hormone receptor gene-disrupted (GHR-KO) mice attenuates phenotypic features of slow aging.生长激素受体基因敲除(GHR-KO)小鼠中胰岛素敏感性的特异性抑制减弱了缓慢衰老的表型特征。
Aging Cell. 2014 Dec;13(6):981-1000. doi: 10.1111/acel.12262. Epub 2014 Sep 20.
5
Adiponectin as a new paradigm for approaching Alzheimer's disease.脂联素作为治疗阿尔茨海默病的新范例。
Anat Cell Biol. 2013 Dec;46(4):229-34. doi: 10.5115/acb.2013.46.4.229. Epub 2013 Dec 24.
6
Decreased levels of circulating adiponectin in mild cognitive impairment and Alzheimer's disease.在轻度认知障碍和阿尔茨海默病患者中,循环脂联素水平降低。
Neuromolecular Med. 2013 Mar;15(1):115-21. doi: 10.1007/s12017-012-8201-2. Epub 2012 Sep 28.
7
Energy expenditure and aging.能量消耗与衰老。
Ageing Res Rev. 2010 Jan;9(1):1-11. doi: 10.1016/j.arr.2009.08.002. Epub 2009 Aug 19.